Noah S Kalman

8PUBLICATIONS
52CO-AUTHORS
Predictive and prognostic markersRegenerative medicine (incl. stem cells)Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 08, 2026
Utility of Early Post-Treatment Circulating Tumor Tissue Modified Viral HPV DNA Testing in HPV-Associated Oropharyngeal Cancer.

|Sep 15, 2026
Longitudinal Improvements in Treatment Delivery Efficiency for MR-Guided Radiation Therapy: An 8-Year Single-Institution Experience.

|May 28, 2025
A Two-Stage Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Ec-18 in Altering the Severity and Course of Oral Mucositis Secondary to Chemoradiation Therapy for Squamous Cell Cancers of the Head and Neck.

|Apr 14, 2025
Hypofractionated Radiotherapy for Soft Tissue Sarcomas.

Mehmet Murat Zerey, Amna Gul, Noah S Kalman

|Jan 25, 2025
Evolving Trends and Patterns of Utilization of Magnetic Resonance-Guided Radiotherapy at a Single Institution, 2018-2024.

Robert A Herrera, Eyub Y Akdemir, Rupesh Kotecha

|Aug 11, 2023
Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance.

Glenn J Hanna, Scott A Roof, Jamie Jabalee

Pageof 2

Frequent Collaborators

3 joint publications

Sreenija Yarlagadda

3 joint publications

Rupesh R Kotecha

2 joint publications

Jamie Jabalee

2 joint publications

Eric M Genden